Scholarship Opportunities for 2024 entry

We are pleased to offer up to two NHLI scholarships for Home students (UK and Ireland only) for 2024 entry who have applied for our course in Genes, Drugs and Stem Cells - Novel Therapies.

• One scholarship is for £7,000 (this will cover 50% of the MSc Genes, Drugs and Stem Cells programme Home tuition fee)
  
• One scholarship is for £14,000  (this will cover 100% of the MSc Genes, Drugs and Stem Cells programme Home tuition fee)

Eligibility

These awards are open to new Home students (UK and Ireland only) making an application to the MSc Genes Drugs and Stem Cells programme to start in 2024.

The focus of these scholarships is to increase access to postgraduate study at Imperial for people from under represented groups. You can see further guidance on the Office for Students webpages on who may be considered an under represented group in Higher Education

It is not essential for applicants to have already received an offer of a place on a programme, but the initial programme application must have been started before applying for a scholarship.

How to apply

Applications should be submitted through our application form.

You will be asked to provide a personal statement outlining why you want to study with us and what you aspire to do on completion of the MSc.

Guidance to applicants on the personal statement

Take your time to compose your personal statement. Be yourself.

The best personal statements are based on the applicant’s own honest reflections about their plans and the way to get there. You may need to make more than one draft before submitting your final statement.

The question is really asking, “based on what you know about the course, why do you want to do the MSc and what do you hope to 'take away' from it that will support your future career plans?”.

Please evidence how your studying at Imperial will increase the diversity within the student body and/or how you fall within an under represented group. See Office for Student webpage for guidance on 'under represented groups'.

Deadline

Applications for 2024 entry are now open. Deadline is 31st May 2024. The decision will be communicated by the end of July to all applicants.

Terms and conditions

When applying for these scholarships, candidates agree to Imperial's terms and conditions regarding scholarships and bursaries.

Please note, the following conditions override the standard Imperial terms and conditions:

• Both part-time and full-time students are eligible to apply.
• An offer of a place is not required before applying, but candidates must first apply for a Master's programme run by the NHLI before applying for either of these Scholarships.
• Candidates who do not apply through the online scholarship form will not be considered for the Faculty of Medicine Master's Scholarships.
• The decision of the selection panel is final. No appeal process is available and we are unable to provide feedback to unsuccessful candidates.
• Awards cannot be deferred or used to fund non-PGT programmes within the Faculty of Medicine, or programmes run by other faculties or schools at Imperial or elsewhere.
• Although your scholarship application will be primarily based on your programme application form, the panel may consult your programme application if it is deemed necessary.
• The continued payment of a Faculty of Medicine Scholarship is subject to satisfactory academic progression on the programme. Award holders will also be required to maintain a minimum class attendance of 80%.
• Faculty of Medicine Master's Scholarships are non-transferable. If you transfer to another institution or withdraw from the College, any payments due to you will be cancelled.
• Awardees will be required to participate in promotional activities during the course of their studies and allow their image to be used by Imperial for publicity purposes. Such activities may include (but are not limited to) attending recruitment events, discussing their experiences with prospective postgraduate students and producing occasional print or web copy.

Contact us with any queries.